[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Next Article in Journal
A Herbal Formula HT048, Citrus unshiu and Crataegus pinnatifida, Prevents Obesity by Inhibiting Adipogenesis and Lipogenesis in 3T3-L1 Preadipocytes and HFD-Induced Obese Rats
Previous Article in Journal
Xerogel-Sequestered Silanated Organochalcogenide Catalysts for Bromination with Hydrogen Peroxide and Sodium Bromide
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 20
Issue 6
10.3390/molecules20069640
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Multidisciplinary Approach to Determine the Optimal Time and Period for Extracting the Essential Oil from Mentha suaveolens Ehrh  †

by
Stefania Garzoli
1,
Adele Pirolli
2,
Elisabetta Vavala
3,
Antonella Di Sotto
4,
Gianni Sartorelli
2,
Mijat Božović
2,
Letizia Angiolella
3,
Gabriela Mazzanti
4,
Federico Pepi
1 and
Rino Ragno
2,*
1
Department of Drug Chemistry and Technology, "Sapienza" University, P.le Aldo Moro 5, 00185 Rome, Italy
2
Rome Center for Molecular Design, Department of Drug Chemistry and Technology, "Sapienza" University, P.le Aldo Moro 5, 00185 Rome, Italy
3
Department of Public Health and Infectious Diseases, "Sapienza" University, P.le Aldo Moro 5, 00185 Rome, Italy
4
Department of Physiology and Pharmacology "Vittorio Erspamer", "Sapienza" University, P.le Aldo Moro 5, 00185 Rome, Italy
*
Author to whom correspondence should be addressed.
†
Rino Ragno dedicates this work to his friend Aldo Peparello, passed away prematurely, without him this study would not have be thought.
Molecules 2015, 20(6), 9640-9655; https://doi.org/10.3390/molecules20069640
Submission received: 13 March 2015 / Revised: 15 May 2015 / Accepted: 18 May 2015 / Published: 26 May 2015
(This article belongs to the Section Natural Products Chemistry)
Browse Figure
Graphical abstract
">
Versions Notes

Abstract

:
A comprehensive study on essential oils (EOs) extracted from some Mentha suaveolens L. samples, collected in the countryside of Tarquinia, is reported. In this study, the procedure for essential oil preparation, in terms of harvesting and extraction time, was analyzed in detail for the first time. The GC/MS analysis, carried out on 18 samples, revealed that piperitenone oxide (PO), the main essential oils’ chemical constituent, is primarily responsible for the related antifungal activity. Nevertheless, EOs with lower PO content indicate that other chemicals, such as para-cymenene, may participate in exerting the EOs’ antifungal effect. Furthermore, the bacterial reverse mutation assay highlighted lack of mutagenic effect in all tested samples. Analysis of the results indicated that for higher activity, the essential oils should be produced with 3 h maximum hydrodistillation, regardless of the harvesting time. Differently, the maximum essential oil yield can be obtained in August and the highest piperitenone oxide percentage is obtainable in July.

Graphical Abstract">

Graphical Abstract

1. Introduction

Antimicrobial properties of essential oils (EOs) are continuously investigated both in vitro [1,2] and in vivo [3,4] against a wide range of pathogenic bacteria and fungi. Among practical uses, the use of EOs as feed and food additives for the control of gastrointestinal tract pathogens has been suggested [5,6,7]. In clinical settings, EOs’ topical use is the most promising strategy for both skin and mucous membranes [8]. EOs are generally obtained by hydro or steam distillation from various plant sources and, among them, the genus Mentha is an important source of basic raw materials [9]. EOs extracted from various plants of mint genus have been extensively investigated for their biological and antimicrobial activities. However, many of them remain to be thoroughly investigated. In particular, the chemical composition of the essential oil extracted from Mentha suaveolens Ehrh is highly variable and depends on several factors among which the most important is the easy hybridization of the Mentha species [10,11,12], the harvesting time [13,14], the geographic area [14,15,16,17,18,19,20,21,22,23,24,25] and the part of the plant extracted [26]. A bibliographic survey carried out in Scopus search engine (www.scopus.com, accessed 8 October 2014) revealed that 48 individual articles mentioned the words “Mentha suaveolens essential oil” (EOMS) although only a 10th actually reported details on the chemical composition.
As extensively reported by Lawrence and Šarić-Kundalić, M. suaveolens can be classified as “spicatae” line on the basis of the inflorescence characters, but for a more detailed classification the characterization of monoterpenes (reflecting three major metabolic pathways) contained in the essential oil is required [14,19].
Recently, we have focused on the extraction of EOs from wild plants of M. suaveolens, collected in the Tarquinia countryside [4,27,28,29] highlighting motivating antimicrobial activities, with a potency against Candida albicans similar to that of antifungal drugs [4,27]. The chemical composition of the M. suaveolens essential oil from Tarquinia (TEOMS) indicates that, in this region, the plant mostly developed carvon metabolic pathways [14], due to the presence of piperitenone oxide (PO) as the major component. Based on this consideration, the antimicrobial activity found for TEOMS was mainly ascribed to this monoterpene, although deeper investigations are required to ascertain the actual PO mechanism of action. Among the different reported EO extraction methods, TEOMS was mainly obtained by hydrodistillation, using a Clevenger-type apparatus for 3–4 h. During our research on TEOMS, it was observed that, either shortening or extending the hydrodistillation time, a different chemical composition of the essential oil could be obtained with some variation in the related biological activity. As a consequence, to obtain the optimal chemical composition of TEOMS, two main questions arise: “When the plant has to be harvested?” and “How long should the hydrodistillation time be?”
Due to weather conditions, difficulties in reaching the M. suaveolens field located in the Tarquinia area and the wild growth of the plant, the period to study TEOMS was restricted to the summer season. Concerning the second question, a fractional hydrodistillation protocol was applied to assess the optimal time of extraction. Herein, in line with our previous studies [4,27], we report a comprehensive study on the TEOMS chemical composition and the related antifungal activity. Furthermore, in order to assess TEOMS safety, mutagenicity studies were carried out on some representative samples.

2. Results and Discussion

2.1. Essential Oil Extraction

Fresh aerial parts from M. suaveolens were subjected to hydrodistillation and the oil was collected at various times (1, 2, 3, 6, 12 and 24 h, Table 1 and Supplemental Material Figure S1) on three different days (see Material and Methods Section). The amount of essential oil varied in function of both the extraction day and the separation intervals. In August and September, the essential oil yields (0.19% and 0.18%, respectively) were more than 2.5 times those of July (0.07%, Table 1), nevertheless the oils showed similar profiles at various extraction times and on the different days. The highest amounts were obtained during the first three extraction phases (1 to 3 h) and the last 12 h of extraction (12 to 24 h). Particularly, during the first three hours, about 70%, 54% and 51% of essential oil was extracted in July, August and September, respectively. Considering the classical hydrodistillation procedure, always reported to be over in three hours [15,16,24] from data reported in Table 1, the extraction yield would have been 0.05%, 0.10% and 0.09% for July, August and September, respectively.
Table
Table 1. Amount of essential oil (grams) over time and relative yield % calculated on the fresh plant material.
Table 1. Amount of essential oil (grams) over time and relative yield % calculated on the fresh plant material.
h 1JulyAugustSeptember
EO (g)Yield %EO (g)Yield %EO (g)Yield %
10.730.031.670.071.320.05
21.050.042.140.092.270.09
31.170.052.580.102.350.09
61.280.053.090.122.490.10
121.420.063.630.152.750.11
241.720.074.760.194.590.18
1 h = extraction hours.

2.2. GC/MS EO Analysis

The GC/MS analysis of the 18 TEOMS samples highlighted the presence of 48 different chemical constituents (Supplemental Material Table S2), having different concentrations in the various fractions. In general, the most abundant compound was piperitenone oxide (PO), characteristic for the TEOMS chemotype. Based on the extraction time, PO percentage reached the maximum during the first three hours (J1h, A2h and S3h, Table 2, Table 3 and Table 4, Supplemental Material Figure S2) to diminish during the last three extraction phases (J6h, J12h and J24h) until disappearing in the J24h and A24h extracts. The component was particularly abundant in July (87%) and August (77%) samples.
Table
Table 2. Chemical composition of TEOMS extracted in July. Values are in % weight rounded to the second decimal place.
Table 2. Chemical composition of TEOMS extracted in July. Values are in % weight rounded to the second decimal place.
# 1NameSample 2
J1hJ2hJ3hJ6hJ12hJ24h
1(−)-spathulenol2.178.188.9914.23 18.35
43-octanol0.18
53-octanol acetate0.11
6α-cadinene 0.24
7α-cadinol 0.501.759.0910.697.62
8α-cubebene0.300.31 0.09
13β-bourbonene0.17
22borneol0.12
23calamenene0.582.092.523.7510.634.32
24carbitol 0.55 2.36
25β-caryophyllene oxide5.3213.6712.6514.375.279.24
26cinerolone0.170.09 7.71
27citronellylacetate 0.633.215.45
28copaene 0.06 0.76
29cubenol0.20 1.927.466.174.24
31δ-cadinene 0.12 4.89
32demelverine0.590.512.189.5243.4620.28
34eucarvone0.08
36gamma-cadinene 0.86
37p-cymen-8-ol0.12
38p-menth-1-en-8-ol0.14
40piperitenone oxide87.2570.5965.5626.0314.00
41tau-cadinol 0.721.39 1.37
42tau-muurolol 0.181.232.14 3.29
46verbenone1.291.15 2.986.566.43
47veridiflorol1.212.482.497.59 2.83
1 # indicate the compound identification number; 2 Samples names were obtained by merging the month first letter and extraction time as reported in Table 1.
Table
Table 3. Chemical composition of TEOMS extracted in August. Values are in % weight rounded to the second decimal place.
Table 3. Chemical composition of TEOMS extracted in August. Values are in % weight rounded to the second decimal place.
# 1NameSample 2
A1hA2hA3hA6hA12hA24h
1(−)-spathulenol0.791.482.472.120.32
43-octanol0.73 0.110.07
53-octanol acetate2.081.020.90
7α-cadinol 0.780.480.09
8α-cubebene5.074.3610.083.640.450.14
10 α-pharnesene5.158.0116.549.092.560.37
11α-phellandrene0.11
12α-pinene1.84
14p-cymenene0.870.332.547.7418.2435.22
15β-elemene 0.380.07
16β-myrcene1.42
17β-ocymene0.59
18β-pharnesene0.731.032.292.240.890.18
19β-phellandrene0.42
20β-pinene0.68
21bicyclosesquiphellandrene0.880.982.371.890.41
22borneol0.280.290.390.370.300.20
23calamenene0.441.071.561.330.65
25β-caryophyllene oxide0.500.321.048.3017.2512.93
26cinerolone 23.1234.4938.79
28copaene 0.790.47
29cubenol 0.360.090.04
30d-limonene6.22
31δ-cadinene0.090.271.072.321.540.44
32demelverine0.131.103.147.468.825.90
33eucalyptol4.210.47
36δ-cadinene 0.510.260.06
37p-cymen-8-ol0.210.540.660.940.970.55
39p-menthone0.390.462.635.705.612.25
40piperitenone oxide65.0577.5150.0116.902.43
44thymol 0.390.320.24
46verbenone0.270.310.812.473.142.58
47veridiflorol 0.390.17
48ylangene0.850.431.500.64
1 # indicate the compound identification number; 2 Samples names were obtained by merging the month first letter and extraction time as reported in Table 1.
Table
Table 4. Chemical composition of TEOMS extracted in September. Values are in % weight rounded to the second decimal place.
Table 4. Chemical composition of TEOMS extracted in September. Values are in % weight rounded to the second decimal place.
# 1NameSample 2
S1hS2hS3hS6hS12hS24h
1(−)-spathulenol3.678.952.543.621.690.99
2(z)-jasmone 0.54
32-caren-10-al 0.320.76
43-octanol 3.134.740.820.611.19
53-octanol acetate 4.902.200.150.120.15
7α-cadinol0.34 0.491.731.220.44
8α-cubebene 0.231.970.961.70
9α-muurolene0.09 0.130.510.580.15
10α-pharnesene1.6010.150.1112.096.426.31
12α-pinene 0.83
14p-cymenene 0.83 1.095.0426.64
16β-myrcene 0.35
17β-ocymene 0.25
18β-pharnesene0.301.320.115.463.230.48
19β-phellandrene 0.10
21bicyclosesquiphellandrene 0.192.331.160.77
22borneol 0.230.340.14
23calamenene1.683.011.261.871.210.80
25β-caryophyllene oxide14.1614.086.305.779.656.37
26cinerolone18.82 2.6613.0418.96
28copaene0.180.210.311.551.670.49
29cubenol0.401.770.701.440.840.18
30d-limonene 0.69 4.84
31delta-cadinene0.89 0.143.053.331.25
32demelverine6.230.681.842.464.905.22
33eucalyptol 1.160.43 2.24
35eugenol1.42 2.073.160.55
37p-cymen-8-ol1.679.220.3726.7724.684.52
38p-menth-1-en-8-ol 0.550.200.880.720.22
39p-menthone 4.461.211.573.61
40piperitenone oxide38.6935.6469.5213.205.535.61
43terpinen-4-ol 0.160.30 0.16
44thymol1.34 0.251.040.15
45trans-2-caren-4-ol 0.20
46verbenone8.111.982.303.685.482.28
47veridiflorol0.421.740.991.800.960.28
48ylangene 0.830.310.46
1 # indicate the compound identification number; 2 Samples names were obtained by merging the month first letter and extraction time as reported in Table 1.
Other constituents are characteristic of the extraction time and become important only starting from or after the fourth fractions (6 h). In particularly, in July, demelverine (32), present in all samples, showed percentages of about 0.5% to 2.0% in the first three hours (J1h–J3h) of extraction to rapidly grow up to more than 43% at 12 h extraction (J12h). The same compound in August increased from about 0.1% (A1h) to only 8.8% (A12h). Still in August, p-cymenene and cinerolone were found as characterizing compounds for the last fractions (A24h). The first one was always contained in all the samples, increasing from about 0.87% (A1h) to a maximum of 35.22% (A24h). Cinerolone was absent in the samples collected during the first three hours of extraction (A1h–A3h),while showing high percentage in the next three phases, reaching the maximum amount of about 38.8% after 24 h of extraction (A24h). A third different composition scenario was found in September, although piperitenone oxide was still the most abundant compound, with other randomly distributed components. Medium-high percentages of β-caryophyllene oxide (14.16%) and cinerolone (18.82%) were found after the first hour of extraction (S1h). After the 2h extraction (S2h), β-caryophyllene oxide decreased while cinerolone disappeared. This last compound appeared again after five hours (S6h) up to the last extraction (S24h), with a percentage varying from 2.66% to 18.96%. Other important chemical components, including α-farnesene (about 12% in S6h), p-cymenene (more than 26% in S24h) and p-cymen-8-ol (about 25% in the S6h and S12h extractions) were also found. Notably, the complexity of the OE chemical composition increased from July to September, being sample S24h—with 36 different chemical components out of the 48—the most complex one (Table 4 and Supplemental Material Figure S3). GC analyses were carried out twice showing reproducible results, nevertheless, no statistical analyses were performed. For comparison purposes, Table 2, Table 3 and Table 4 are also reported as united tables in Supplemental Material Table S3.

2.3. Antimicrobial Assay

The in vitro antifungal activity of TEOMS extracted at different times and in different summer months, against the reference strain C. albicans ATCC 10231, is reported in Table 5. The results are representative of two independent experiments arranged in triplicate. With few exceptions, the MIC of this strain ranged from 0.1 mg∙mL−1, to 0.02 mg∙mL−1 for TEOMS extracted in July and August, and 0.1 to 0.2 mg∙mL−1 for TEOMS extracted in September, and, in all cases, the extracts showing an interesting antifungal activity were in the first three hours of extraction. For the TEOMS extracted from six to 24 h, the MIC values ranged from 6.25 to 12.5 mg∙mL−1. TEOMS extracted in the first 3 h showed good antifungal activities, and in one particular case, extract A2h (Supplemental Material Figure S2 and Table 3), the anticandida activity was comparable to that of miconazole (Table 5 and Supplemental Material Table S1) [30], a well-known marketed antifungal synthetic drug. Analysis of results in Table 3, Table 4, Table 5 and Table 6 clearly indicates that PO is very likely the chemical components responsible for the antifungal activities reported in Table 6. In fact, the most active mixtures are those containing higher PO percentages. Decreasing of the PO% led to lower active TEOMS except for the most complex mixture S24h where the antifungal activity is only about two times lower than J1h (highest PO%) and about seven times lower than A2h, the highest active TEOMS. Inspecting PO%, it is clear that it is not the only important constituent, and likely other minor chemicals are endowed with microbiological activities and may co-participate in the inhibition process with some synergistic mechanism similar to that reported recently by us [31,32]. The S24h (Table 4 and Supplemental Material Figure S3) chemical complexity could explain the low micromolar antifungal activity (Supplemental Material Table S1) and is somehow in agreement with the phytocomplex hypothesis reported in many other experimental observations [33,34]. Further analysis of data in Table 6 indicates the lack of any correlation between the antimicrobial activity and the cultivation stage of the plant, thus supporting the previous reported data that PO is mainly responsible for the antimicrobial activity. Somehow, this is in contrast with some bibliographic data reporting that EOs obtained during flowering season of a plant exhibit the most significant antimicrobial activity [26,35,36].
Table
Table 5. Anti-Candida albicans activities of the 18 TEOMS extracts.
Table 5. Anti-Candida albicans activities of the 18 TEOMS extracts.
Sample 1MIC mg∙mL−1PO %
J1h0.1087.25
J2h0.1070.59
J3h0.1065.56
J6h6.2526.03
J12h6.2514.78
J24h12.50-
A1h0.1065.05
A2h0.0277.51
A3h0.1050.01
A6h0.7816.90
A12h3.122.43
A24h6.25-
S1h0.2038.69
S2h0.2035.64
S3h0.1069.52
S6h6.2513.20
S12h6.255.53
S24h0.205.61
Miconazole0.016
1 Samples names were obtained by merging the month first letter and extraction time as reported in Table 1.

2.4. Mutagenicity Test

The mutagenicity assays were carried out on three TEOMS samples, namely J1h, A1h and S1h, being the most abundant and showing the strongest antimicrobial activities against Candida albicans. The three samples were firstly assayed for their cytotoxicity in the strains tested and were found to be not cytotoxic up to 400 μg∙plate−1 (J1h), 50 μg∙plate−1 (A1h) and 100 μg∙plate−1 (S1h), respectively (Table 6). The presence of the metabolic activator S9 seemed to reduce the cytotoxicity of all three samples (Table 6). The cytotoxicity profile could be due to the different compositions of the three samples. In particular, J1h appeared to be the less toxic one; in contrast, A1h exerted the highest cytotoxicity in TA100.
Based on these results, we carried out the mutagenicity test using concentrations lower than that found in the preliminary test (viz. J1h, 10 to 350 for all strains; A1h and S1h, 10 to 150 μg∙plate−1 for TA98 and WP2uvrA, and 10 to 50 μg∙plate−1 for TA100). In the absence of the metabolic activation system, the samples of TEOMS did not produce any increase in the number of revertant colonies for S. typhimurium TA98 and TA100 and in E. coli WP2uvrA, so resulting in them not being mutagenic. Likewise, no mutagenic effects were observed in the presence of S9; these results allow hypothesizing that no genotoxic derivatives were produced from the CYP450-mediated biotransformation of the TEOMS components (Table 8). Conversely, the reference mutagens, 2NF, 2AA, SA and MMS increased the number of revertant colonies about four to eight times with respect to the vehicle control, showing the suitability of the system to detect a genotoxic effect (Table 7).
Present results highlight that the three samples of TEOMS, carrying a different phytochemical composition, exhibited a similar marked antimicrobial activity without inducing mutagenic effects. Overall, the phytocomplex contained in the TEOMS samples appears not to be mutagenic, although the toxicity of each component is not always investigated. In this context, it should be underlined the presence of some compounds, including β-caryophyllene oxide, d-limonene and eucalyptol, known to possess genoprotective properties [37,38,39,40]. It could be argued that for sample A1h (Table 6) the number of revertants could be too low. Nevertheless, the number of revertants “0.3 ± 0.2 **t” for sample A1h, at the concentration of 850 μg∙plate−1 makes sense: its low value stems from the fact that, at this concentration, A1h is toxic, as indicated by the symbol “t”. The toxicity causes a reduction of the number of revertant colonies with respect to the negative control (vehicle DMSO, Table 6). For the same reason, in the mutagenicity test (Table 7), the higher concentration used of 150 µg∙plate−l did not show cytotoxicity and did not reduce the number of revertant colonies.
Table
Table 6. Cytotoxicity of J1h, A1h, and S1h samples from Mentha suaveolens essential oil on Salmonella ser. typhimurium TA98 and TA100 and of Escherichia coli WP2uvrA strains, in the absence and presence of the metabolic activator S9 (means ± SEM; n = 9 plates).
Table 6. Cytotoxicity of J1h, A1h, and S1h samples from Mentha suaveolens essential oil on Salmonella ser. typhimurium TA98 and TA100 and of Escherichia coli WP2uvrA strains, in the absence and presence of the metabolic activator S9 (means ± SEM; n = 9 plates).
SampleCompound Amount (μg∙plate−1)Number of Revertant Colonies
TA98TA100WP2uvrA
−S9+S9−S9+S9−S9+S9
J1h5044.0 ± 1.159.3 ± 1.8153.3 ± 10.9162.3 ± 2.648.2 ± 3.450.0 ± 2.5
10045.2 ± 2.153.7 ± 3.5162.8 ± 10.2149.2 ± 7.142.0 ±6.867.0 ± 3.7
25043.7 ± 3.358.8 ± 3.7146.7 ± 8.3152.0 ± 8.338.3 ± 1.858.8 ± 11.9
40038.0 ± 3.062.7 ± 6.3136.0 ± 8.3149.3 ± 3.244.2 ± 2.863.7 ± 3.7
55029.7 ± 3.4 **,t56.5 ± 6.773.7 ± 11.2 **,t129.7 ± 5.432.5 ± 5.0 ~t57.2 ± 6.8
85015.0 ± 1.1 **,t30.3 ± 2.8 **,t40.0 ± 10.6 **,t97.0 ± 2.3 **,t19.3 ± 3.7 **,t34.7 ± 6.7 **,t
A1h5049.3 ± 3.868.0 ± 7.9144.0 ± 14.0133.3 ± 23.642.7 ± 3.577.3 ± 5.8
10041.3 ± 3.560.7 ± 7.390.7 ± 14.3 **,t127.3 ± 12.643.1 ± 4.974.7 ± 13.2
25041.3 ± 3.5 **,t60.0 ± 7.373.3 ± 32.8 **,t124.0 ± 16.1 ~t32.0 ± 4.8 **,t77.3 ± 1.3
40032.7 ± 4.3 **,t30.4 ± 4.5 **,t79.3 ± 7.4 **,t106.7 ± 3.1 **,t25.3 ± 3.3 **,t57.3 ± 11.9 **,t
55025.3 ± 3.4 **,t28.7 ± 9.4 **,t64.0 ± 16.5 **,t104.7 ± 8.3 **,t30.7 ± 3.4 **,t28.7 ± 2.8 **,t
8500.3 ± 0.2 **,t0.5 ± 0.1 **,t11.3 ± 5.2 **,t111.3 ± 8.7 **,t2.1 ± 0.1 **,t12.1 ± 0.5 **,t
S1h5053.3 ± 1.354.7 ± 8.1153.3 ± 4.8177.3 ± 7.459.3 ± 5.958.2 ± 3.4
10054.0 ± 7.550.2 ± 6.7153.3 ± 9.8173.3 ± 13.350.7 ± 4.358.0 ± 5.0
25040.0 ± 2.3 **,t61.3 ± 7.1139.3 ± 9.9 **,t170.7 ± 9.349.3±6.1 ~t54.2 ± 2.8
40053.3 ± 3.5 **,t56.7 ± 4.8 **,t138.7 ± 6.4 **,t146.0 ± 13.6 ~t46.0 ± 5.2 ~t52.0 ± 3.1 ~t
55017.3 ± 7.4 **,t38.7 ± 9.3 **,t117.3 ± 8.6 **,t150.7 ± 10.7 **,t44.7 ± 8.5 **,t38.0 ± 2.3 **,t
8505.1 ± 0.3 **,t11.8 ± 0.6 **,t37.3 ± 12.5 **,t49.3 ± 13.8 **,t22.1 ± 1.3 **,t17.8 ± 0.9 **,t
Vehicle 43.3 ± 2.8 a49.3 ± 2.1 a143.2 ± 13.6 a153.6 ± 17.1 a45.9 ± 5.2 a59.7 ± 5.3 a
Mutagen 128.1 ± 8.1 b186.1 ± 15.1 c608.5 ± 14.9 d 379.2 ± 23.5 c 287.4 ± 17.2 e323.7 ± 20.4 f
t Toxicity (evaluated as >70% reduction of the number of revertant colonies vs. vehicle); ~t Minor toxicity (evaluated as a change in the auxotrophic background growth vs. vehicle). a DMSO 50 µL; b 2-Nitrofluorene (2 μg∙plate−1); c 2-Aminoanthracene (1 μg∙plate−1); d Sodium azide (1 μg∙plate−1); e Methyl methane sulfonate (500 μg∙plate−1); f 2-Aminoanthracene (10 μg∙plate−1); ** p < 0.01 vs. vehicle (Anova + Dunnett’s multiple comparison post-test).
Table
Table 7. Effect of J1h, A1h, and S1h samples from Mentha suaveolens essential oil on the number of spontaneous revertant colonies of Salmonella ser. typhimurium TA98 and TA100 and of Escherichia coli WP2uvrA strains, in the absence and presence of the metabolic activator S9 (means ± SEM; n = 9 plates).
Table 7. Effect of J1h, A1h, and S1h samples from Mentha suaveolens essential oil on the number of spontaneous revertant colonies of Salmonella ser. typhimurium TA98 and TA100 and of Escherichia coli WP2uvrA strains, in the absence and presence of the metabolic activator S9 (means ± SEM; n = 9 plates).
SampleCompound Amount (μg∙plate−1)Number of Revertant Colonies
TA98TA100WP2uvrA
−S9+S9−S9+S9−S9+S9
J1h1046.0 ± 2.359.0 ± 3.2133.3 ± 14.8150.5 ± 15.449.3 ± 7.460.0 ± 2.3
5044.0 ± 1.159.3 ± 1.8146.7 ± 8.3129.7 ± 5.448.2 ± 3.450.0 ± 2.5
10038.0 ± 3.053.7 ± 3.5162.8 ± 10.2149.2 ± 7.139.5 ± 5.067.0 ± 3.7
15040.0 ± 1.855.7 ± 6.4163.3 ± 11.8155.3 ± 2.438.0 ± 5.060.2 ± 5.4
25043.7 ± 3.358.8 ± 3.7136.0 ± 8.3152.0 ± 8.338.3 ± 1.858.8 ± 11.9
35045.2 ± 2.162.7 ± 6.3153.3 ± 10.9149.3 ± 3.244.2 ± 2.863.7 ± 3.7
A1h10 (10)55.1 ± 6.848.9 ± 5.2134.4 ± 13.2140.8 ± 19.752.0 ± 5.465.8 ± 7.2
50 (18)49.3 ± 3.868.0 ± 7.9144.0 ± 14.0133.3 ± 23.642.7 ± 3.577.3 ± 5.8
75 (25)42.7 ± 3.762.0 ± 3.1160.8 ± 14.3130.0 ± 18.245.3 ± 5.359.0 ± 9.2
100 (36)41.3 ± 3.560.7 ± 7.3170.0 ± 11.5148.0 ± 4.643.1 ± 4.974.7 ± 13.2
150 (50)56.0 ± 11.160.0 ± 7.3155.1 ± 8.8155.6 ± 10.435.3 ± 1.668.0 ± 12.9
S1h10 (10)56.7 ± 6.864.0 ± 4.2178.0 ± 13.1138.0 ± 8.253.5 ± 3.659.3 ± 7.4
50 (18)53.3 ± 1.364.7 ± 8.1153.3 ± 4.8177.3 ± 7.459.3 ± 5.958.2 ± 3.4
75 (25)64.0 ± 7.770.2 ± 4.3177.3 ± 12.7145.5 ± 10.354.2 ± 4.359.5 ± 3.7
100 (36)64.0 ± 7.570.2 ± 6.7168.3 ± 3.8169.7 ± 17.850.7 ± 4.358.0 ± 5.0
150 (50)61.3 ± 5.868.0 ± 4.9155.3 ± 14.4146.7 ± 6.752.0 ± 9.258.5 ± 1.4
Vehicle 47.7 ± 2.5 a52.7 ± 2.7 a157.1 ± 8.1 a153.6 ± 17.1 a48.2 ± 3.2 a66.5 ± 3.9 a
Mutagen 149.7 ± 10.6 b,**266.1 ± 25.1 c,**995.8 ± 85.9 d,**379.2 ± 23.5 c,**323.4 ± 31.2 e,**347.4 ± 16.4 f,**
a DMSO 50 µL; b 2-Nitrofluorene (2 μg∙plate−1); c 2-Aminoanthracene (1 μg∙plate−1); d Sodium azide (1 μg∙plate−1); e Methyl methane sulfonate (500 μg∙plate−1); f 2-Aminoanthracene (10 μg∙plate−1). ** p < 0.01 vs. vehicle (Anova + Dunnett’s multiple comparison post-test).

3. Experiment Section

3.1. Plant Material

Aerial parts of MS were collected in a wild area about 10 Km from Tarquinia city (Viterbo, Italy, latitude 42°20'23.3406", longitude 11°46'16.3452", Supplemental Material Figure S4) in three different days (7 July, 24 August and 28 September 2011). Since every year the MS field is completely ploughed, the age of the plants was less than one year.

3.2. Essential Oil Extractions

Fresh aerial parts of the plant material (about 2.5 kg) were subjected to hydrodistillation using a 62 L steel distillator apparatus (Albrigi Luigi E0131, Verona, Italy) separating oils at interval time of 1, 2, 3, 6, 12 and 24 h. At each interval, the accumulated oil/water double phase (50 mL) was extracted three times with diethyl ether (20 mL). The organic layers were then dried on anhydrous Na2SO4, filtered and private of the solvent in vacuo to furnish pale yellow oils.

3.3. Essential Oil Analysis

GC/MS conditions. The gas chromatographic/mass spectrometric (GC/MS) analysis was carried out with a GC-MS and GC-FID by using a turbomass Clarus 500 GC-MS/GC-FID from Perkin Elmer instruments (Waltham, MA, USA). A Stabilwax fused-silica capillary column (Restek, Bellefonte, PA, USA) (60 m × 0.25 mm, 0.25 mm film thickness) was used with helium as carrier gas (1.0 mL∙min−1). GC oven temperature was kept at 60 °C for 5 min and programmed to 220 °C at a rate of 5 °C∙min−1, and kept constant at 220 °C for 30 min. Solvent delay 0–2 min. and scan time 0.2 s. MS was taken at 70 eV. Mass range was from 30 to 350 m/z. 1 μL of the extract was diluted in 1 mL of methanol and 1 μL of the solution was injected into the GC injector at the temperature of 280 °C.
The main components of essential oils were identified at first by GC injection of analytical standard compounds comparing their retention times with those obtained in the essential oil analysis. A second confirmation was performed by GC-MS by comparison of the mass spectra with those characteristic of the standard sample and, if not commercially available, with the NIST and NBS Libraries (https://library.nist.gov/). Relative abundances of the separated components were derived by using the same instrumentation with the FID detector configuration.

3.4. Antimicrobial Assay

The Minimum Inhibitory Concentration (MIC) was determined by micro-broth dilution method (microsterile plate) according to the Clinical and Laboratory Standards Institute/National Committee for Clinical Laboratory Standards (CLSI/NCCLS) Approved Standard M27-A3, 2008 [NCCLS]. The MIC was determined as the lowest concentration of drugs or essential oils at which no microbial growth was observed. Miconazole 0.5 mg∙mL−1 solution was prepared dissolving the agent in endotoxin free water. Solutions of essential oil (100 mg∙mL−1) were prepared in RPMI 1640. Briefly, to determine the MIC of TEOMS extracted at different times and in different months, or miconazole, RPMI-1640 supplemented with MOPS at pH 7 was used. TEOMS was diluted in RPMI-1640 supplemented with Tween 80 (final concentration of 0.001% v/v). The dilutions, 11 increasing concentrations, ranging from 0.012 to 12.48 mg∙mL−1 of the essential oil, were prepared in 96 well plates. The inoculum size was about 2.5 × 103 cells∙mL−1. The plates were incubated at 30 °C for 24–48 h.

3.5. Mutagenicity Tests

Chemicals and S9-based metabolic activation system. All the substances used in the Ames test, including the mutagens 2-nitrofluorene (2NF) (CAS number 607-57-8; purity 98%), 2-aminoanthracene (2AA) (CAS number 613-13-8; purity 96%), sodium azide (SA) (CAS number 26628-22-8; purity > 99.5%), methyl methane sulfonate (MMS) (CAS number 66-27-3; purity 99%), and the media were obtained from Sigma-Aldrich Co (St. Louis, MO, USA). The TEOMS samples and the mutagens 2NF and 2AA were dissolved in DMSO (CAS number 67-68-5; purity > 99.5%), while SA and MMS in deionised water.
S9 fraction (the liver post mitochondrial supernatant of rats treated with the mixture phenobarbital/β-naphthoflavone to induce the hepatic microsomal enzymes) was purchased from Moltox (Molecular Toxicology, Boone, NC, USA) and prepared just before use by adding: phosphate buffer (0.2 M) 500 µL, deionised water 130 µL, KCl (0.33 M) 100 µL, MgCl2 (0.1 M) 80 µL, S9 fraction 100 µL, glucose-6-phosphate (0.1 M) 50 µL and NADP (0.1 M) 40 µL. The final mixture was kept on ice during testing.
Bacterial strains. Salmonella ser. typhimurium TA98 (hisD3052gal biochl1008rfa1001 uvrBpKM101), S. typhimurium TA100 (hisG56galbiochl1005rfa1004 ΔuvrB pKM101) and Eschericia coli WP2uvrA (trpE65ΔuvrA) were kindly supplied by the Research Toxicological Centre (Pomezia, Rome, Italy). The genotypes of these strains were confirmed by testing the presence of specific genetic markers, in preliminary Strain Check Assays [41]; thus, the permanent cultures were prepared and frozen. The working cultures, used in each experiment, were obtained from the frozen permanent cultures after incubation overnight (16 h) at 37 °C to reach a concentration of approximately 1 × 109 bacteria∙mL−1. In each experiment, the number of viable cells for each strain was defined according to Di Sotto et al. [41].
Preliminary assays. Preliminarily, the solubility in the final treatment mixture of three samples of M. suaveolens essential oil was assessed, in order to find the highest concentration to use in the following assays. Insolubility was defined as the formation of a precipitate in the final mixture evident to unaided eye. All the samples did not give any precipitate up to the highest concentration tested of 850 μg∙plate−1 (corresponding to 320 μg∙mL−1). Starting from this concentration, serial dilutions (dilution factor from 1:1.2 to 1:2.5) was prepared and tested in the cytotoxicity assay. Cytotoxic effects were evaluated as a reduction (>70%) in the number of revertant colonies and as a change in the auxotrophic background growth (background lawn), in comparison with the control plates [41]. To perform the test, solutions of test substances (50 µL) were added to an overnight culture (100 µL) and S9 mixture or phosphate buffer (0.1 M; 500 µL). The mixture was pre-incubated under shaking at 37 °C for 30 min, then it was added with top agar (2 mL) containing 10% of histidine/biotin (0.5 mM) for TA98 and TA100, and 10% of tryptophan (0.5 mM) for WP2uvrA; finally it was poured onto a minimal agar plate. After incubation at 37 °C for 48 h, the plates were examined, the background lawn was observed and the bacterial colonies were scored.
Mutagenicity assays. Mutagenicity of the substances was assayed using the pre-incubation method [41]. Different dilutions (dilution factor from 1:1.2 to 1:1.5) of the three samples of OEMS were prepared starting from the highest non-toxic concentration. Therefore, their effect on the spontaneous revertant colonies of TA98, TA100 and WP2uvrA strains was tested in comparison with the vehicle (DMSO, 2% v/v; negative control). In each experiment, some plates treated with known mutagens (positive controls) were also included, in order to verify the ability of the experimental system to detect a genotoxic effect. As mutagens we used 2-nitrofluorene (2NF; 2 μg∙plate−1 for TA98), sodium azide (SA; 1 μg∙plate−1 for TA100) and methyl methanesulfonate (MMS; 500 μg∙plate−1 for WP2uvrA), in the absence of the metabolic activator S9, while 2-aminoanthracene (2AA; 1 μg∙plate−1 for TA98 and TA100 and 10 μg∙plate−1 for WP2uvrA) in the presence of S9. These concentrations of mutagens, obtained from the linear part of the concentration-response curve, were chosen as they increased the number of revertant colonies at least two-fold above the control value. The experiments were repeated at least twice and each concentration was tested in triplicate. To perform the test, an overnight culture (100 µL) was added to the solutions of the samples tested (50 µL) plus S9 mixture or phosphate buffer (0.1 M) (500 µL). The mixture was gently vortexed in a sterile tube then was incubated under shaking at 37 °C for 30 min. After the pre-incubation, the tubes were added with top agar (2 mL) containing 10% of histidine/biotin (0.5 mM) for TA98 and TA100, and 10% of tryptophan (0.5 mM) for WP2uvrA, then were gently vortexed and poured onto a minimal agar plate. The plates were incubated at 37 °C for 72 h and then examined. The histidine- or tryptophan-independent revertant colonies and the viable cells were scored and the bacterial background lawn was observed. A positive response in the test was defined as an increase (at least two-fold above the control) in histidine- or tryptophan-independent revertant colonies in each strain [41].
Statistical analysis. All values are expressed as mean ± SE. The one-way analysis of variance (one-way ANOVA), followed by Dunnett’s multiple comparison post-test, was used to verify the significance of a positive response. A p value < 0.05 was considered statistically significant. Statistical analysis was performed with GraphPad Prism™ (Version 4.00) software (GraphPad Software, Inc., San Diego, CA, USA).

4. Conclusions

In recent years, the interest in essential oils has continually increased; nevertheless, no detailed study on the extraction procedure has yet been reported considering both extraction time and period. In line with our previous studies on TEOMS, a systematic extraction procedure was applied to three different periods during the summer of 2011, and at various extraction times. In order to monitor the biological variability, the essential oils were assayed by means of a classical antimicrobial protocol that suggested piperitenone oxide as the principal active chemical constituent responsible for the antifungal activity. Although this was somewhat an expected result, the herein systematic procedure revealed that other constituents may participate actively in the biological effect. In particular, the extract S24h, although lacking piperitenone oxide, revealed a single digit micromolar activity (pMIC = 5.92, Supplemental Material Table S1) that can be mainly ascribed to the whole mixture where some of them act in a synergistic way and some act uncooperatively; as a matter of fact, sample A2h is five times more effective than sample J1h which contains less PO (compare their compositions in Table 2, Table 3 and Table 5). It could be speculated that for A2h, α-cadinol and α-cubebene (the more abundant components after PO) could have some positive and additive biological role; on the other hand, for J1h it could be that α-pharnesene (the most abundant after PO) could demonstrate some anti-synergism with PO. The lack of mutagenic effect in the tested essential oils somewhat supports the safe use of Mentha suaveolens essential oil as a food additive. In conclusion, from data herein presented, the answers to the questions in the introduction can be partially answered. In relation to the biological activity, the period of extraction seems to be of marginal importance as any essential oil collected in the first three hours showed similar anti-candida activity and was deprived of any mutagenicity effects. On the other hand, consideration should also be given to the EO production yield or the chemical composition. Harvesting in August lead to the higher EO production, while in July the higher piperitenone oxide percentage was obtained. Regarding the second question (How long should the hydrodistillation time be?), the answer depends on what the study is conducted for. To obtain EOs with the highest PO content, hydrodistillation of 1 to 3 must be undertaken, while for extraction of different components, like p-cymenene, cinerolone and demelverine, 24 h of hydrodistillation should be carried out.

Supplementary Materials

Supplementary materials can be accessed at: https://www.mdpi.com/1420-3049/20/06/9640/s1.

Acknowledgments

R.R. thanks Università Agraria di Tarquinia, for the support in obtaining the fresh plant of Mentha suaveolens. A.D.S. was supported by “Enrico and Enrica Sovena Foundation”—Rome, Italy.

Author Contributions

RR initiated and designed the work. RR, GS, AP and MB performed the plant harvesting, cleaning, essential oil hydrodistillations and storage. SG made all the GC/MS analyses with deep investigation on each oil components. FP critically reviewed all the GC/MS analyses. EV and LA performed microbiological analyses. ADS and GM performed the mutagenicity test. RR coordinated the whole work, collected the literature references, collaborated with all the authors and made most of the comments. All the authors finalized and critically edited the manuscript before submission. RR compiled the final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kalemba, D.; Kunicka, A. Antibacterial and antifungal properties of essential oils. Curr. Med. Chem. 2003, 10, 813–829. [Google Scholar] [CrossRef] [PubMed]
  2. Reichling, J.; Schnitzler, P.; Suschke, U.; Saller, R. Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties—An overview. Forsch. Komplementmed. 2009, 16, 79–90. [Google Scholar] [CrossRef] [PubMed]
  3. Naveed, R.; Hussain, I.; Mahmood, M.S.; Akhtar, M. In vitro and in vivo evaluation of antimicrobial activities of essential oils extracted from some indigenous spices. Pak. Vet. J. 2013, 33, 413–417. [Google Scholar]
  4. Pietrella, D.; Angiolella, L.; Vavala, E.; Rachini, A.; Mondello, F.; Ragno, R.; Bistoni, F.; Vecchiarelli, A. Beneficial effect of mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection. BMC Complement. Altern. Med. 2011, 11. [Google Scholar] [CrossRef] [PubMed]
  5. Hammer, K.A.; Carson, C.F.; Riley, T.V. Antimicrobial activity of essential oils and other plant extracts. J. Appl. Microbiol. 1999, 86, 985–990. [Google Scholar] [CrossRef] [PubMed]
  6. Si, W.; Ni, X.; Gong, J.; Yu, H.; Tsao, R.; Han, Y.; Chambers, J.R. Antimicrobial activity of essential oils and structurally related synthetic food additives towards Clostridium perfringens. J. Appl. Microbiol. 2009, 106, 213–220. [Google Scholar] [CrossRef] [PubMed]
  7. Si, W.; Gong, J.; Tsao, R.; Zhou, T.; Yu, H.; Poppe, C.; Johnson, R.; Du, Z. Antimicrobial activity of essential oils and structurally related synthetic food additives towards selected pathogenic and beneficial gut bacteria. J. Appl. Microbiol. 2006, 100, 296–305. [Google Scholar] [CrossRef] [PubMed]
  8. Low, W.L.; Martin, C.; Hill, D.J.; Kenward, M.A. Antimicrobial efficacy of silver ions in combination with tea tree oil against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans. Int. J. Antimicrob. Agents 2011, 37, 162–165. [Google Scholar] [CrossRef] [PubMed]
  9. Lawrence, B.M. Mint. The Genus Mentha, 1st, ed.; Series: Medicinal and Aromatic Plants—Industrial Profiles; CRC Press: Boca Raton, FL, USA, 2006. [Google Scholar]
  10. Arthur, T.; Robert, N. An overview of its classification and relationships. In Mint The Genus Mentha; CRC Press: Boca Raton, FL, USA, 2006; Chapter 1. [Google Scholar]
  11. Harley, R.M.; Brighton, C.A. Chromosome numbers in the genus Mentha L. Bot. J. Linn. Soc. 1977, 74, 71–96. [Google Scholar] [CrossRef]
  12. Sobti, S. Chromosome numbers in species of Mentha. Proc. Indian AS-Math Sci. B 1965, 62, 145–148. [Google Scholar]
  13. Deschamps, C.; Zanatta, J.L.; Bizzo, H.R.; Oliveira, M.C.; Roswalka, L.C. Seasonal evaluation of essential oil yield of mint species. Ciênc. Agrotecnol. 2008, 32, 725–730. [Google Scholar] [CrossRef]
  14. Šarić-Kundalić, B.; Fialová, S.; Dobeš, C.; Ölzant, S.; Tekeľová, D.; Grančai, D.; Reznicek, G.; Saukel, J. Multivariate numerical taxonomy of Mentha species, hybrids, varieties and cultivars. Sci. Pharm. 2009, 77, 851–876. [Google Scholar] [CrossRef]
  15. Aziz, E.E.; Craker, L.E. Essential oil constituents of peppermint, pennyroyal, and apple mint grown in a desert agrosystem. J. Herbs Spices Med. Plants 2009, 15, 361–367. [Google Scholar] [CrossRef]
  16. Başer, K.H.C.; Kürkçüoǧlu, M.; Demirci, B.; Özek, T.; Tarimcilar, G. Essential oils of Mentha species from Marmara region of Turkey. J. Essent. Oil Res. 2012, 24, 265–272. [Google Scholar] [CrossRef]
  17. Baser, K.H.C.; Kürkçüoglu, M.; Tarimcilar, G.; Kaynak, G. Essential oils of Mentha species from northern turkey. J. Essent. Oil Res. 1999, 11, 579–588. [Google Scholar] [CrossRef]
  18. Brada, M.; Bezzina, M.; Marlier, M.; Lognay, G.C. Chemical composition of the leaf oil of Mentha rotundifolia (L.) from Algeria. J. Essent. Oil Res. 2006, 18, 663–665. [Google Scholar] [CrossRef]
  19. Brian, L. Oil composition of other mentha species and hybrids. In Mint. The Genus Mentha; CRC Press: Boca Raton, FL, USA, 2006; Chapter 8. [Google Scholar]
  20. Derwich, E.; Benziane, Z.; Boukir, A. Antibacterial activity and chemical composition of the leaf essential oil of mentha rotundifolia from Morocco. J. Environ. Agric. Food Chem. 2010, 9, 19–28. [Google Scholar]
  21. Derwich, E.; Benziane, Z.; Taouil, R.; Senhaji, O.; Touzani, M. Comparative essential oil composition of leaves of mentha rotundifolia and mentha pulegium a traditional herbal medicine in Morocco. Am. -Eurasian J. Sust. Agric. 2010, 4, 47–54. [Google Scholar]
  22. Karousou, R.; Balta, M.; Hanlidou, E.; Kokkini, S. “Mints”, smells and traditional uses in Thessaloniki (Greece) and other Mediterranean countries. J. Ethnopharmacol. 2007, 109, 248–257. [Google Scholar] [CrossRef] [PubMed]
  23. Mohamed, S.B.; Eddine, A.D. Antibacterial activity of essential oils of some algerian aromatic plants against multidrug resistant bacteria. J. Essent. Oil Bear. Plants 2010, 13, 362–370. [Google Scholar] [CrossRef]
  24. Sutour, S.; Bradesi, P.; Casanova, J.; Tomi, F. Composition and chemical variability of Mentha suaveolens ssp. suaveolens and M. suaveolens ssp. insularis from Corsica. Chem. Biodivers. 2010, 7, 1002–1008. [Google Scholar] [PubMed]
  25. Sutour, S.; Bradesi, P.; de Rocca-Serra, D.; Casanova, J.; Tomi, F. Chemical composition and antibacterial activity of the essential oil from Mentha suaveolens ssp. insularis (Req.) Greuter. Flavour Fragr. J. 2008, 23, 107–114. [Google Scholar] [CrossRef]
  26. Burt, S. Essential oils: Their antibacterial properties and potential applications in foods—A review. Int. J. Food Microbiol. 2004, 94, 223–253. [Google Scholar] [CrossRef] [PubMed]
  27. Angiolella, L.; Vavala, E.; Sivric, S.; Diodata, D.A.F.; Ragno, R. Letter: In vitro activity of mentha suaveolens essential oil against cryptococcus neoformans and dermatophytes. Int. J. Essent. Oil Ther. 2010, 4, 35–36. [Google Scholar]
  28. Ragno, R.; Sivric, S.; Sartorelli, G.; Serilli, A.; Vavala, E.; Angiolella, L. In vitro activity of essential oil of Myrtus communis L. against Candida albicans. Int. J. Essent. Oil Ther. 2008, 2, 156–157. [Google Scholar]
  29. Vavala, E.; Ragno, R.; Sivric, S.; Sartorelli, G.; Filippi, A.; Palamara, A.T.; Angiolella, L. Antimycotic activity of Achillea ageratum L. essential oil. Int. J. Essent. Oil Ther. 2009, 3, 101–105. [Google Scholar]
  30. Miconazole (Oravig) for oropharyngeal candidiasis. Med. Lett. Drugs Ther. 2010, 52, 95–96.
  31. Stringaro, A.; Vavala, E.; Colone, M.; Pepi, F.; Mignogna, G.; Garzoli, S.; Cecchetti, S.; Ragno, R.; Angiolella, L. Effects of mentha suaveolens essential oil alone or in combination with other drugs in Candida albicans. Evid. -Based Complement. Altern. Med. 2014, 2014, 125904. [Google Scholar] [CrossRef] [PubMed]
  32. Vavala, E.; Passariello, C.; Pepi, F.; Colone, M.; Garzoli, S.; Ragno, R.; Pirolli, A.; Stringaro, A.; Angiolella, L. Antibacterial activity of essential oils mixture against PSA. Nat. Prod. Res. 2015, 2015. [Google Scholar] [CrossRef] [PubMed]
  33. Neto, A.C.; Netto, J.C.; Pereira, P.S.; Pereira, A.M.; Taleb-Contini, S.H.; Franca, S.C.; Marques, M.O.; Beleboni, R.O. The role of polar phytocomplexes on anticonvulsant effects of leaf extracts of Lippia alba (Mill.) N.E. Brown chemotypes. J. Pharm. Pharmacol. 2009, 61, 933–939. [Google Scholar] [CrossRef] [PubMed]
  34. Maietti, S.; Rossi, D.; Guerrini, A.; Useli, C.; Romagnoli, C.; Poli, F.; Bruni, R.; Sacchetti, G. A multivariate analysis approach to the study of chemical and functional properties of chemo-diverse plant derivatives: Lavender essential oils. Flavour Fragr. J. 2013, 28, 144–154. [Google Scholar] [CrossRef]
  35. Chorianopoulos, N.; Kalpoutzakis, E.; Aligiannis, N.; Mitaku, S.; Nychas, G.J.; Haroutounian, S.A. Essential oils of Satureja, Origanum, and Thymus species: Chemical composition and antibacterial activities against foodborne pathogens. J. Agric. Food. Chem. 2004, 52, 8261–8267. [Google Scholar] [CrossRef] [PubMed]
  36. Chorianopoulos, N.; Evergetis, E.; Mallouchos, A.; Kalpoutzakis, E.; Nychas, G.J.; Haroutounian, S.A. Characterization of the essential oil volatiles of Satureja thymbra and Satureja parnassica: Influence of harvesting time and antimicrobial activity. J. Agric. Food. Chem. 2006, 54, 3139–3145. [Google Scholar] [CrossRef] [PubMed]
  37. Di Sotto, A.; Evandri, M.G.; Mazzanti, G. Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay. Mutat. Res. 2008, 653, 130–133. [Google Scholar]
  38. Di Sotto, A.; Maffei, F.; Hrelia, P.; Castelli, F.; Sarpietro, M.G.; Mazzanti, G. Genotoxicity assessment of β-caryophyllene oxide. Regul. Toxicol. Pharm. 2013, 66, 264–268. [Google Scholar] [CrossRef] [PubMed]
  39. Di Sotto, A.; Mazzanti, G.; Carbone, F.; Hrelia, P.; Maffei, F. Inhibition by beta-caryophyllene of ethyl methanesulfonate-induced clastogenicity in cultured human lymphocytes. Mutat. Res. 2010, 699, 23–28. [Google Scholar] [CrossRef] [PubMed]
  40. Di Sotto, A.; Durazzi, F.; Sarpietro, M.G.; Mazzanti, G. Antimutagenic and antioxidant activities of some bioflavours from wine. Food Chem. Toxicol. 2013, 60, 141–146. [Google Scholar] [CrossRef] [PubMed]
  41. Di Sotto, A.; Maffei, F.; Hrelia, P.; di Giacomo, S.; Pagano, E.; Borrelli, F.; Mazzanti, G. Genotoxicity assessment of some cosmetic and food additives. Regul. Toxicol. Pharm. 2014, 68, 16–22. [Google Scholar] [CrossRef] [PubMed]
  • Sample Availability: Not available.

Share and Cite

MDPI and ACS Style

Garzoli, S.; Pirolli, A.; Vavala, E.; Di Sotto, A.; Sartorelli, G.; Božović, M.; Angiolella, L.; Mazzanti, G.; Pepi, F.; Ragno, R. Multidisciplinary Approach to Determine the Optimal Time and Period for Extracting the Essential Oil from Mentha suaveolens Ehrh . Molecules 2015, 20, 9640-9655. https://doi.org/10.3390/molecules20069640

AMA Style

Garzoli S, Pirolli A, Vavala E, Di Sotto A, Sartorelli G, Božović M, Angiolella L, Mazzanti G, Pepi F, Ragno R. Multidisciplinary Approach to Determine the Optimal Time and Period for Extracting the Essential Oil from Mentha suaveolens Ehrh . Molecules. 2015; 20(6):9640-9655. https://doi.org/10.3390/molecules20069640

Chicago/Turabian Style

Garzoli, Stefania, Adele Pirolli, Elisabetta Vavala, Antonella Di Sotto, Gianni Sartorelli, Mijat Božović, Letizia Angiolella, Gabriela Mazzanti, Federico Pepi, and Rino Ragno. 2015. "Multidisciplinary Approach to Determine the Optimal Time and Period for Extracting the Essential Oil from Mentha suaveolens Ehrh " Molecules 20, no. 6: 9640-9655. https://doi.org/10.3390/molecules20069640

APA Style

Garzoli, S., Pirolli, A., Vavala, E., Di Sotto, A., Sartorelli, G., Božović, M., Angiolella, L., Mazzanti, G., Pepi, F., & Ragno, R. (2015). Multidisciplinary Approach to Determine the Optimal Time and Period for Extracting the Essential Oil from Mentha suaveolens Ehrh . Molecules, 20(6), 9640-9655. https://doi.org/10.3390/molecules20069640

Article Metrics

Back to TopTop